Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 160.19 |
---|---|
High | 160.19 |
Low | 160.19 |
Bid | 159.01 |
Offer | 159.69 |
Previous close | 160.19 |
Average volume | -- |
---|---|
Shares outstanding | 121.70m |
Free float | 121.35m |
P/E (TTM) | 53.04 |
Market cap | 13.52bn USD |
EPS (TTM) | 2.09 USD |
Annual div (ADY) | 0.2483 CHF |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Oct 18 2024 |
Div pay-date | Nov 08 2024 |
Next div ex-date | Jan 17 2025 |
Next div pay-date | Feb 07 2025 |
Data delayed at least 15 minutes, as of Jan 19 2022.
More ▼
Press releases
- Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK
- Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference
- Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells
- Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation
- Revvity Announces Financial Results for the Third Quarter of 2024
- Revvity Board Declares Quarterly Dividend
- Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories
- Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report
- Revvity To Hold Earnings Call on Monday, November 4, 2024
- Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene
More ▼